One peptide is straightforward. Two peptides require some thought. Three or more peptides require a system. Most women researching peptide therapy are considering multi-compound protocols — a GH secretagogue for sleep and body composition, BPC-157 for gut healing, GHK-Cu for skin — and the practical question of how to organize the daily routine doesn't get enough attention.
This guide covers the principles. Your specific protocol should be designed with a clinician who knows your compounds, your health history, and your goals.
Principle 1: Timing to pharmacology
Each peptide has an optimal timing window based on its mechanism and the physiological processes it targets.
GH secretagogues (Sermorelin, CJC-1295/Ipamorelin, Tesamorelin, MK-677): Before bed, on an empty stomach. The rationale is twofold: GH secretion naturally peaks during the first few hours of sleep (particularly during slow-wave sleep), and insulin elevation from food blunts the GH response. Most protocols specify injection 30-60 minutes before sleep, at least 2 hours after the last meal.
BPC-157: Flexible timing. BPC-157 can be taken morning or evening. If you're using it for gut healing, some clinicians suggest splitting the dose (morning and evening) to maintain more consistent tissue exposure. If you're using it for injury repair, timing closer to the injury site's rest period (evening) is sometimes preferred. The evidence for optimal BPC-157 timing is thin — consistency matters more than clock position.
GHK-Cu (injectable): Morning or evening, depending on your protocol. If combined with a GH secretagogue, some clinicians recommend separating them by 12 hours — GHK-Cu in the morning, GH secretagogue at night — to avoid potential interactions at the injection site.
PT-141 (Bremelanotide): As needed, 45 minutes before anticipated sexual activity. This is an on-demand peptide, not a daily protocol. No more than one dose per 24 hours, no more than 8 doses per month (per the FDA-approved label for Vyleesi).
Selank and Semax (nasal): Morning or as needed. Both are short-acting nasal peptides. Selank (anxiolytic) is often used morning and early afternoon. Semax (cognitive) is used during periods requiring focus. Neither interferes with evening GH protocols.
Principle 2: Stacking order and injection site separation
When injecting multiple peptides in the same session, use different injection sites. Abdominal fat offers several distinct sites (rotate clockwise: left of navel, above navel, right of navel, below navel). Separate injection sites by at least 2 inches.
Some peptides can be mixed in the same syringe if they're compatible (same diluent, no chemical interaction). Your compounding pharmacy or prescribing provider can advise on which combinations are safe to co-mix. When in doubt, separate syringes, separate sites.
Principle 3: Cycling and rest periods
Receptor desensitization is the biological reason for cycling. When a receptor is continuously stimulated, it can downregulate — reducing its sensitivity to the signal. The result is diminishing returns from the same dose.
Common cycling patterns in functional medicine practice:
5/2 weekly cycle: Five days on, two days off (typically weekends). This is the gentlest cycling approach and is commonly used for GH secretagogues and BPC-157.
Block cycling: 8-12 weeks on, 4 weeks off. This is more common for compounds where receptor downregulation is a documented concern, or for protocols where periodic lab assessment (IGF-1, metabolic panel) is used to monitor response.
Seasonal cycling: Some women cycle peptides around life events — using a recovery stack post-surgery, a GH stack during a training block, a skin stack before a significant event. This is practical rather than pharmacological cycling, but it naturally introduces rest periods.
Principle 4: Menstrual cycle considerations
This is the least evidence-supported principle, but it's clinically relevant for premenopausal and perimenopausal women.
Follicular phase (days 1-14): Estrogen is rising. GH secretion is naturally higher during this phase. Some clinicians reduce GH secretagogue dosing during the late follicular phase to avoid excessive GH response.
Ovulation (day 14): LH surges. If you're using Kisspeptin for hormonal support, timing around ovulation requires careful coordination with your reproductive endocrinologist — Kisspeptin directly influences the GnRH-LH axis.
Luteal phase (days 15-28): Progesterone rises, estrogen fluctuates. Sleep disruption is common in the late luteal phase. Some women report better sleep response to GH secretagogues during this window.
Menstruation (days 1-5): Inflammation markers are naturally elevated. BPC-157 and other anti-inflammatory peptides may provide additional comfort during this window, though this is anecdotal rather than evidence-based.
A sample framework (not a prescription)
This is a structural example of how a multi-peptide day might be organized. It is not a dosing guide or a medical recommendation. Your specific compounds, doses, and timing should be determined by your provider.
Morning (fasted or with light meal): BPC-157 (if using for gut), GHK-Cu (if using injectable), Selank nasal (if using for anxiety/mood).
Evening (2+ hours after dinner, 30-60 min before bed): GH secretagogue (Sermorelin or CJC-1295/Ipamorelin). BPC-157 second dose (if splitting for gut protocol).
As needed: PT-141 (45 min before activity). Semax nasal (focus periods).
The goal is a routine you can sustain. The most pharmacologically optimized protocol means nothing if you abandon it after two weeks because it requires four separate injection times and a spreadsheet. Start with one or two compounds, get the routine dialed in, and add complexity only when the basics are habit.